These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 24361955)

  • 1. Interaction of stable colloidal nanoparticles with cellular membranes.
    Mahmoudi M; Meng J; Xue X; Liang XJ; Rahman M; Pfeiffer C; Hartmann R; Gil PR; Pelaz B; Parak WJ; Del Pino P; Carregal-Romero S; Kanaras AG; Tamil Selvan S
    Biotechnol Adv; 2014; 32(4):679-92. PubMed ID: 24361955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor extracellular acidity-activated nanoparticles as drug delivery systems for enhanced cancer therapy.
    Du JZ; Mao CQ; Yuan YY; Yang XZ; Wang J
    Biotechnol Adv; 2014; 32(4):789-803. PubMed ID: 23933109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exocytosis of nanoparticles from cells: role in cellular retention and toxicity.
    Sakhtianchi R; Minchin RF; Lee KB; Alkilany AM; Serpooshan V; Mahmoudi M
    Adv Colloid Interface Sci; 2013 Dec; 201-202():18-29. PubMed ID: 24200091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biophysical characterization of nanoparticle-endothelial model cell membrane interactions.
    Peetla C; Labhasetwar V
    Mol Pharm; 2008; 5(3):418-29. PubMed ID: 18271547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in nanomedicines for malaria treatment.
    Aditya NP; Vathsala PG; Vieira V; Murthy RS; Souto EB
    Adv Colloid Interface Sci; 2013 Dec; 201-202():1-17. PubMed ID: 24192063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications.
    Fadeel B; Garcia-Bennett AE
    Adv Drug Deliv Rev; 2010 Mar; 62(3):362-74. PubMed ID: 19900497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein-Nanoparticle Interaction-Induced Changes in Protein Structure and Aggregation.
    Kim Y; Ko SM; Nam JM
    Chem Asian J; 2016 Jul; 11(13):1869-77. PubMed ID: 27062521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colloidal systems for drug delivery: from design to therapy.
    Beija M; Salvayre R; Lauth-de Viguerie N; Marty JD
    Trends Biotechnol; 2012 Sep; 30(9):485-96. PubMed ID: 22673692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A spontaneous penetration mechanism of patterned nanoparticles across a biomembrane.
    Li Y; Zhang X; Cao D
    Soft Matter; 2014 Sep; 10(35):6844-56. PubMed ID: 25082334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomedicine: Interaction of biomimetic apatite colloidal nanoparticles with human blood components.
    Choimet M; Hyoung-Mi K; Jae-Min O; Tourrette A; Drouet C
    Colloids Surf B Biointerfaces; 2016 Sep; 145():87-94. PubMed ID: 27137807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique benefits of nanotechnology to drug delivery and diagnostics.
    McNeil SE
    Methods Mol Biol; 2011; 697():3-8. PubMed ID: 21116949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticles in medicine: therapeutic applications and developments.
    Zhang L; Gu FX; Chan JM; Wang AZ; Langer RS; Farokhzad OC
    Clin Pharmacol Ther; 2008 May; 83(5):761-9. PubMed ID: 17957183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticles: cellular uptake and cytotoxicity.
    Adjei IM; Sharma B; Labhasetwar V
    Adv Exp Med Biol; 2014; 811():73-91. PubMed ID: 24683028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymer/colloid surface micromachining: micropatterning of hybrid multilayers.
    Mohammed JS; McShane M
    Langmuir; 2008 Dec; 24(23):13796-803. PubMed ID: 18989945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming in vivo barriers to targeted nanodelivery.
    Chrastina A; Massey KA; Schnitzer JE
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(4):421-37. PubMed ID: 21538941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology.
    Ilinskaya AN; Dobrovolskaia MA
    Nanomedicine (Lond); 2013 May; 8(5):773-84. PubMed ID: 23656264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theoretical and computational investigations of nanoparticle-biomembrane interactions in cellular delivery.
    Ding HM; Ma YQ
    Small; 2015 Mar; 11(9-10):1055-71. PubMed ID: 25387905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secreted biomolecules alter the biological identity and cellular interactions of nanoparticles.
    Albanese A; Walkey CD; Olsen JB; Guo H; Emili A; Chan WC
    ACS Nano; 2014 Jun; 8(6):5515-26. PubMed ID: 24797313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrochemical biosensing with nanoparticles.
    Merkoçi A
    FEBS J; 2007 Jan; 274(2):310-6. PubMed ID: 17181547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticles as protein and gene carriers to mucosal surfaces.
    de la Fuente M; Csaba N; Garcia-Fuentes M; Alonso MJ
    Nanomedicine (Lond); 2008 Dec; 3(6):845-57. PubMed ID: 19025458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.